Patents by Inventor Claude Prigent

Claude Prigent has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7514231
    Abstract: The invention concerns a monoclonal antibody directed against mammalian aurora-A kinase, the method for obtaining same, as we ll as its uses in cancer diagnosis and prognosis, and in pharmaceutical compositions for cancer treatment.
    Type: Grant
    Filed: June 12, 2003
    Date of Patent: April 7, 2009
    Assignees: Centre National de la Recherche Scientifique, Etablissement Francais du Sang-Bretagne
    Inventors: Claude Prigent, Anne Martin
  • Publication number: 20080008712
    Abstract: The present invention relates to a peptide sequence characterized in that it comprises or is constituted by a fragment of at least approximately 10 amino acids originating from the following sequence SEQ ID NO: 1: TPVQNKRRRSpVTPPEEQQE SEQ ID NO: 1 in which the serine residue in position 10 is phosphorylated, said above-mentioned fragment containing said phosphorylated serine residue. The present invention also relates to a polyclonal or monoclonal antibody capable of recognizing a peptide sequence as defined above.
    Type: Application
    Filed: June 8, 2004
    Publication date: January 10, 2008
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE DE RENNES 1, UNIVERSITE PAUL SABATIER TOULOUSE III
    Inventors: Bernard Ducommun, Bernard Monsarrat, Claude Prigent
  • Publication number: 20070117163
    Abstract: The invention concerns a monoclonal antibody directed against mammalian aurora-A kinase, the method for obtaining same, as well as its uses in cancer diagnosis and prognosis, and in pharmaceutical compositions for cancer treatment.
    Type: Application
    Filed: June 12, 2003
    Publication date: May 24, 2007
    Inventors: Claude Prigent, Anne Martin